CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapy

Tumor Grade and Matrix Metalloproteinase 2 Expression in Stromal Fibroblasts Help to Stratify the High-Risk Group of Patients With Early Breast Cancer Identified on the Basis of St Gallen Recommendations

(2013) Joanna Niemiec et al.   Clinical Breast Cancer

Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity

(2012) Appalaraju Jaggupilli et al.   Clinical & Developmental Immunology

CD24 Expression as a Marker for Predicting Clinical Outcome in Human Gliomas

(2012) Jianping Deng et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Breast-cancer stem cells—beyond semantics

(2012) Sunil Badve et al.   LANCET ONCOLOGY

Differential Response of Immunohistochemically Defined Breast Cancer Subtypes to Anthracycline-Based Adjuvant Chemotherapy with or without Paclitaxel

(2012) George Fountzilas et al.   PLoS One

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

CD44+/CD24−/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome

(2011) Michael O. Idowu et al.   HUMAN PATHOLOGY

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype

(2011) S. Ricardo et al.   JOURNAL OF CLINICAL PATHOLOGY

The expression of PCNA, c-erbB-2, p53, ER and PR as well as atypical hyperplasia in tissues nearby the breast cancer

(2011) Zongliang Jia et al.   JOURNAL OF MOLECULAR HISTOLOGY

Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: An immunohistochemistry-based pilot study

(2011) Zhen Wang et al.   PATHOLOGY RESEARCH AND PRACTICE

Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules

(2011) Monther Al-Alwan et al.   PLoS One

Triple Negative Breast Cancer: Outcome Correlation With Immunohistochemical Detection of Basal Markers

(2010) Aye Aye Thike et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status

(2010) Hee Jeong Kim et al.   BREAST

Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer

(2010) Gottfried E. Konecny et al.   BREAST CANCER RESEARCH AND TREATMENT

Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer

(2010) S. Y. Park et al.   CLINICAL CANCER RESEARCH

Clinicopathological Significance of Invasive Ductal Carcinoma with High Prevalence of CD44+/CD24-/lowTumor Cells in Breast Cancer

(2010) Ji-Youn Sung et al.   Korean Journal of Pathology

Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer

(2009) Carey K. Anders et al.   Clinical Breast Cancer

Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers

(2009) T. Tanei et al.   CLINICAL CANCER RESEARCH

Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

(2009) Judith Hugh et al.   JOURNAL OF CLINICAL ONCOLOGY

CD24 expression has a prognostic impact in breast carcinoma

(2009) Pauline Athanassiadou et al.   PATHOLOGY RESEARCH AND PRACTICE